Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-16T19:11:33.218Z Has data issue: false hasContentIssue false
  • English
  • Français

A Hospital Epidemic of Vancomycin-Resistant Enterococcus Risk Factors and Control

Published online by Cambridge University Press:  02 January 2015

Karin E. Byers ,
Anne M. Anglim ,
Cynthia J. Anneski ,
Teresa P. Germanson ,
Howard S. Gold ,
Lisa J. Durbin ,
Barbara M. Simonton  and
Barry M. Farr
Karin E. Byers
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Anne M. Anglim
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Cynthia J. Anneski
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Teresa P. Germanson
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Howard S. Gold
Affiliation:
Harvard Medical School, Boston, Massachusetts
Lisa J. Durbin
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Barbara M. Simonton
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
Barry M. Farr*
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
*
Box 800473, University of Virginia Health System, Charlottesville, VA 22908
Get access Rights & Permissions [Opens in a new window]

Abstbact

Objective:

To determine risk factors for vancomycin-resistant Enterococcus (VRE) colonization during a hospital outbreak and to evaluate Centers for Disease Control and Prevention (CDC)-recommended control measures.

Design:

Epidemiological study involving prospective identification of colonization and a case-control study.

Setting:

A university hospital.

Participants:

Patients on eight wards involved in outbreak from late 1994 through early 1995.

Methods:

Cases were matched by ward and culture date with up to two controls. Risk factors were evaluated with four multivariate models using conditional logistic regression. The first evaluated proximity to other VRE patients and isolation status. The second evaluated proximity to unisolated VRE cases and three variables independently predictive after adjustment for proximity. The third evaluated seven significant univariate predictors in addition to proximity to unisolated VRE in backward, stepwise logistic regression. The fourth assessed proximity to VRE with all other variables collected, clustered in a principal components analysis. Pulsed-field gel electrophoresis was performed to assess clonality of two outbreak strains.

Results:

The incidence of transmission declined significantly after CDC guidelines were implemented. Proximity to unisolated VRE cases during the prior week was a significant predictor of acquisition in each of four multivariate models. Other significant risk factors in multivariate models included a history of major trauma and treatment with metronidazole. Pulsed-field gel electrophoresis confirmed the clonality of two outbreak strains.

Conclusions:

VRE was transmitted between patients during a hospital epidemic, with proximity to previously unisolated VRE patients being an important risk factor. Weekly surveillance cultures and contact isolation of colonized patients significantly reduced spread.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 3 , March 2001 , pp. 140 - 147
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin—United States, 1989-1993. MMWR 1993;42:597–599.Google Scholar
2. Boyle, JF, Soumakis, SA, Rendo, A, Herrington, JA, Gianarkis, DG, Thurberg, BE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280–1285.CrossRefGoogle ScholarPubMed
3. Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234–1239.Google Scholar
4. Jernigan, JA, Hadziyannis, E, Schwartzman, SC, Nolte, FS. Vancomycin-resistant enterococcus faecium (VRE) bacteremia in severely neutropenic patients. In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1996; New Orleans, LA. Abstract J8, p 219.Google Scholar
5. Stosor, V, Peterson, LR, Postelnick, M, Noskin, GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522–527.Google Scholar
6. Linden, PK, Pasculle, AW, Manez, R, Kramer, DJ, Fung, JJ, Pinna, AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium . Clin Infect Dis 1996;22:663–670.Google Scholar
7. Edmond, MB, Jones, RN, Pfaller, MA, Wallace, SE, Wenzel, RP. Multicenter surveillance for nosocomial enterococcal bacteremia: a comparison of vancomycin-sensitive vs vancomycin-resistant cases. In: Program and Abstracts of the Sixth Annual Meeting of the Society for Healthcare Epidemiology of America; April 21-23, 1996; Washington, DC.1996;17:P18. Abstract 14.Google Scholar
8. Noble, WC, Virani, Z, Cree, RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus . FEMS Microbiol Lett 1992;72:195–198.CrossRefGoogle ScholarPubMed
9. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44:1–13.Google Scholar
10. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380–388.Google Scholar
11. Gaynes, RP, Edwards, J. Nosocomial vancomycin resistant enterococci (VRE) in the United States, 1989-1995: the first 1,000 isolates. Infect Control Hosp Epidemiol 1996;17(5, part 2):18. Abstract 13.Google Scholar
12. Boyce, JM, Opal, SM, Chow, JW, Zervos, MJ, Potter-Bynoe, G, Sherman, CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148–1153.CrossRefGoogle ScholarPubMed
13. Rubin, LG, Tucci, V, Cercenado, E, Elipoulos, G, Isenberg, HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700–705.CrossRefGoogle ScholarPubMed
14. Karanfil, LV, Murphy, M, Josephson, A, Gaynes, RP, Mandel, L, Hill, BC, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195–200.Google Scholar
15. Montecalvo, MA, Horowitz, H, Gedris, C, Carbonaro, C, Tenover, FC, Issah, A, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363–1367.CrossRefGoogle Scholar
16. Byers, KE, Titus, MG, Alexander, CH, Durbin, LJ, Simonton, B, Duani, DK. A hospital outbreak of vancomycin-resistant Enterococcus faecium (VRE) controlled with intensive surveillance culturing and gown and glove isolation. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA. Abstract J41, p 264.Google Scholar
17. Livornese, LL Jr Dias, S, Samel, C, Romanowski, B, Taylor, S, May, P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.CrossRefGoogle ScholarPubMed
18. Dembry, L, Uzokwe, K, Zervos, M. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol 1996;17:286–292.CrossRefGoogle ScholarPubMed
19. Morris, JG Jr Shay, DK, Hebden, JN, McCarter, RJ Jr Perdue, BE, Jarvis, W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250–259.CrossRefGoogle Scholar
20. Slaughter, S, Hayden, MK, Nathan, C, Hu, TC, Rice, T, Van Voorhis, J, et al. A comparison of the effect of universal use of gloves and gown with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448–456.CrossRefGoogle Scholar
21. Garner, JS, Jarvis, W, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.Google Scholar
22. Horan, TC, Gaynes, RP, Martone, WJ, Jarvis, W, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.Google Scholar
23. Wenzel, RP, Osterman, CA, Hunting, KJ, Gwaltney, JM Jr Hospital acquired infection, I: surveillance in a university hospital. Am J Epidemiol 1976;103:251–260.Google Scholar
24. Last, JM. A Dictionary of Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1988.Google Scholar
25. Anglim, AM, Klym, B, Byers, KE, Scheld, WM, Farr, BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium . Arch Intern Med 1997;157:1132–1136.Google Scholar
26. Byers, KE, Durbin, LJ, Simonton, B, Anglim, AM, Adal, KA, Farr, BM. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium . Infect Control Hosp Epidemiol 1998;19:261–264.Google ScholarPubMed
27. Muto, CA, Karchmer, TB, Alexander, CH, Durbin, LJ, Farr, BM. Frequency of community acquired MRSA at a university hospital. In: Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America; September 13-16, 1997; San Francisco, CA. Abstract 347, p 135.Google Scholar
28. Edberg, SC, Hardalo, CJ, Kontnic, C, Campbell, S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol 1994;32:2182–2184.Google Scholar
29. Elipoulos, G, Wennersten, CB, Gold, HS, Schulin, T, Farris, MG, Cerwinka, S, et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristinquinupristin. Antimicrob Agents Chemother 1998;42:1088–1092.CrossRefGoogle Scholar
30. Tenover, FC, Arbeit, RD, Goering, RV, Mickelsen, PA, Murray, BE, Persing, DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.Google Scholar
31. Breslow, N, Day, NE. The analysis of case-control studies. In: International Agency for Research on Cancer, ed. Statistical Methods in Cancer Research. Lyon, France; 1980:248–279.Google Scholar
32. Sun, GW, Shook, TL, Kay, GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996;49:907–916.Google Scholar
33. Harrell, FE, Lee, KL, Califf, RM, Pryor, DB, Rosati, RA. Regression modeling strategies for improved prognostic prediction. Stat Med 1984;3:143–152.CrossRefGoogle ScholarPubMed
34. Doebbeling, BN, Stanley, GL, Sheetz, CT, Pfaller, MA, Houston, AK, Annis, L, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.Google Scholar
35. Albert, RK, Condie, F. Hand-washing patterns in medical intensive-care units. N Engl J Med 1981;304:1465–1466.Google Scholar
36. Pittet, D, Mourouga, P, Perneger, TV. Compliance with handwashing in a teaching hospital. Infection Control Program. Ann Intern Med 1999;130:126–130.Google Scholar
37. Bonilla, HF, Zervos, MA, Lyons, MJ, Bradley, SF, Hedderwick, SA, Ramsey, MA, et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term–care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997;18:333–339.Google Scholar
38. Wells, CL, Juni, BA, Cameron, SB, Mason, KR, Dunn, DL, Ferrieri, P, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45–50.Google Scholar
39. Noskin, GA, Stosor, V, Cooper, I, Peterson, LR. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995;16:577–581.CrossRefGoogle ScholarPubMed
40. Anglim, AM, Farr, BM. Nosocomial gastrointestinal tract infections. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Williams & Wilkins; 1996:196–224.Google Scholar
41. Anglim, AM, Farr, BM. Control of nosocomial gastrointestinal infections. In: Blaser, MJ, Smith, PD, Ravidin, JI, Greenberg, HB, Guerrant, RL, eds. Infections of the Gastrointestinal Tract. New York, NY: Ravens Press, Ltd; 1995:1525–1545.Google Scholar
42. Zervos, MJ, Dembinski, S, Mikesell, T, Schaberg, DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986;153:1075–1083.CrossRefGoogle ScholarPubMed
43. Zervos, MJ, Terpenning, MS, Schaberg, DR, Therasse, PM, Medendorp, SV, Kauffman, CA. High-level aminoglycoside-resistant enterococci: colonization of nursing home and acute care hospital patients. Arch Intern Med 1987;147:1591–1594.CrossRefGoogle ScholarPubMed
44. Snow, J. On the Mode of Communication of Cholera. London, UK: John Churchill; 1855.Google Scholar
45. Francis, DP, Curran, JW, Essex, M. Epidemic acquired immune deficiency syndrome: epidemiologic evidence for a transmissible agent. J Natl Cancer Inst 1983;71:1–4.Google Scholar
46. Cerwinka, S, Murphey, S, Fraimow, H. Epidemiology of vancomycin-resistant enterococci (VRE) at Thomas Jefferson University Hospital (TJUH). In: Program and Abstracts of the Fourth Annual Meeting of the Society for Hospital Epidemiology of America; March 20-22, 1994; New Orleans, LA. Abstract S53, p P32.Google Scholar
47. Smith, SM, O'Donovan, C, Dever, LL, Yamaguchi, E, Eng, RHK. Vancomycin-resistant Enterococcus faceium in a VA Medical Center. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 1994; Orlando, FL. Abstract J156, p 145.Google Scholar
48. Moreno, F, Grota, P, Crisp, C, Magnon, K, Melcher, GP, Jorgensen, JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faceium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234–1237.Google Scholar
49. Tsang, P, Fallon, F, Schulman, M, Jimenez, V. An outbreak of vancomycin-resistant enterococci (VRE) in a suburban VA medical center. In: Program and Abstracts of the Infectious Diseases Society of America 33rd Annual Meeting; September 1995; San Francisco, CA. Abstract 66, p 33.Google Scholar
50. Quale, J, Patel, K, Zaman, M, Saurina, G, Huang, W, Oydna, V. Fecal carriage of vancomycin-resistant enterococci (VRE) in nursing home (NH) and hospitalized patients. In: Program and Abstracts of the Infectious Diseases Society of America 33rd Annual Meeting; September 1995; San Francisco, CA. Abstract 79, p 36.Google Scholar
51. Schaaff, D, Pachucki, C, Adeyanju, T. Risk factors for acquisition of vancomycin-resistant Enterococcus . In: Program and Abstracts of the Fifth Annual Meeting of the Society for Healthcare Epidemiology of America; April 2-4, 1995; San Diego, CA. Abstract M80, p P45.Google Scholar
52. Noskin, GA, Postelnick, M, Yinger, P, Reisberg, BE, Peterson, LR. Third generation cephalosporins are an important risk factor for acquisition of vancomycin resistant enterococci. In: Program and Abstracts of the Infectious Diseases Society of America 33rd Annual Meeting; September 1995; San Francisco, CA. Abstract 95, p 40.Google Scholar
53. Dassey, DE, Lahti, CJ, Mascola, L. Vancomycin-resistant Enterococcus faecium (VREF)—outbreak comparison of analytic methods. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA. Abstract E36, p 91.Google Scholar
54. Handwerger, S, Raucher, B, Altarac, D, Monka, J, Marchione, S, Singh, KV, et al. Nosocomial outbreak due to Enterococcus faceium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750–755.Google Scholar
55. Gordts, B, Claeys, K, Jannes, H, Van Landuyt, HW. Are vancomycin resistant enterococci (VRE) normal inhabitants of the G.I. tract of hospitalized patients? In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 1994;Orlando, FL. Abstract J151, p 144.Google Scholar
56. Revuelta, MP, Nord, JA, Uarrish, RL, Kislak, JW, LaBombardi, V. Recycling of hospital-acquired colonization with vancomycin resistant enterococci via nursing home residents. In: Program and Abstracts of the Infectious Diseases Society of America 33rd Annual Meeting; September 1995; San Francisco, CA. Abstract 61, p 32.Google Scholar
57. Wright, W, Korb, S, Karabaic, M, Reynolds, L, Dunn, P, Hall, G. Prospective study of the epidemiology of vancomycin-resistant enterococcus (VRE) colonization among ICU patients. In: Program and Abstracts of the Fifth Annual Meeting of the Society for Healthcare Epidemiology of America; April 2-4, 1995; San Diego, CA. Abstract 14, p P18.Google Scholar
58. Currie, BP, Gnass, S, Levi, MH. A hospital based stool culture survey to detect vancomycin resistant enterococcus (VRE)—utility and application. In: Program and Abstracts of the Fifth Annual Meeting of the Society for Healthcare Epidemiology of America; April 24, 1995; San Diego, CA. Abstract 15, p P18.Google Scholar
59. Wells, V, Wright, W, Schadow, K, Hall, G. Prior therapy with oral vancomycin increases the risk of rectal colonization with vancomycin-resistant Enterococcus faeeium (VRE). In: Program and Abstracts of the Infectious Diseases Society of America 32nd Annual Meeting; October 1994; Orlando, FL. Abstract 211, p 37–A.Google Scholar
60. Lai, KK, Fontecchio, SA, Kelley, AL, Melvin, ZS. When is it safe to take patients colonized with vancomycin-resistant Enterococcus faceium (VREF) off isolation? In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA. Abstract J36, p 263.Google Scholar
61. Shah, L, Johanson, WG, Smith, SM, Eng, RHK, Dever, LL. Epidemiologic correlation of the incidences of vancomycin-resistant Enterococcus faecium (VREF) infection and Clostridium difficile colitis in a VA medical center. Infect Control Hosp Epidemiol 1996;17(5, part 2):16.Google Scholar
62. Piper, J, McGrail, L, Reichwein, B, Moore, L, Berg, D, Bacon, A. High rate of vancomycin resistant Enterococcus (VRE) in a large teaching hospital; a community based problem? In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA. Abstract J43, p 264.Google Scholar
63. Paul, SM, Silber, JL, Crane, G, Kupersmit, A, Spitalny, K. Vancomycin-resistant enterococcal (VRE) blood isolates in New Jersey (NJ) hospitals: an 18-month statewide study. Infect Control Hosp Epidemiol 1994;15(4, part 2):32. Abstract S52.Google Scholar
64. Shay, DK, Maloney, SA, Montecalvo, M, Banerjee, S, Wormser, GP, Arduino, MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993–1000.Google Scholar
65. Edmond, MB, Ober, JF, Weinbaum, DL, Pfaller, MA, Hwang, T, Sanford, MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.Google Scholar
66. Currie, JB, McNicholl, IR, Hershow, RC. Risk factors for infection with vancomycin-resistant Enterococcus faecium at a VA medical center. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA. Abstract J77, p 271.Google Scholar
67. Issack, MI, Power, EG, Franch, GL. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect 1996;33:191–200.Google Scholar
68. Frost, WH. Epidemiology. In Maxcy, KF, ed. The Papers of Wade Hampton Frost, M.D. New York, NY: The Commonwealth Fund; 1941:493–542.Google Scholar
69. Edmond, MB, Jones, RN, Pfaller, MA, Wallace, SE, Wenzel, RP. Management of vancomycin-resistant enterococci in U.S. hospitals. In: Program and Abstracts of the 33rd Infectious Disease Society of America Annual Meeting; September 1995; San Francisco, CA. Abstract 75, p 35.Google Scholar
70. Quale, J, Landman, D, Saurina, G, Atwood, E, DiTore, V, Patel, K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020–1025.Google Scholar
71. Wright, W, Dedier, H, Zhao, J, Krajden, M, Campbell, I, Weinstein, M. The natural history of carriage of VRE using PCR detection of Van A, Van B, and Van C directly from stool samples/rectal swabs: what we don't know can't hurt us, can it? In: Program and Abstracts of the Eighth Annual Meeting of the Society for Healthcare Epidemiology of America; April 5-7, 1998; Orlando, FL. Abstract 74, p 38.Google Scholar
72. Montecalvo, MA, de Lencastre, H, Carraher, M, Gedris, C, Chung, M, VanHorn, K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium . Infect Control Hosp Epidemiol 1995;16:680–685.CrossRefGoogle ScholarPubMed
73. Byers, KE, Anneski, CJ, Anglim, AM, Dill, JB, Alexander, CH, Duani, DK. Duration of colonization with VRE. In: Program and Abstracts of the Sixth Annual Meeting of the Society for Healthcare and Epidemiology of America; April 21-23, 1996; Washington, DC. Abstract 17, p P18.Google Scholar
74. Maki, DG. Vancomycin resistant enterococci. In: Program and Abstracts of the Sixth Annual Meeting of the Society for Healthcare and Epidemiology of America; April 21-23; Washington, DC. Abstract, p P4.Google Scholar